Clinical trial
Convection-Enhanced Delivery of Glucocerebrosidase to Treat Type 2 Gaucher…
NCT00244582 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00244582 |
|---|---|
| Title | Convection-Enhanced Delivery of Glucocerebrosidase to Treat Type 2 Gaucher Disease |
| Official title | Direct Convection-Enhanced Delivery of Glucocerebrosidase for the Treatment of Type 2 (Acute Neuronopathic) Gaucher Disease |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Type 2 Gaucher Disease |
| Enrollment | 1 |
| Start date | Oct 22, 2005 |
| Completion | Nov 3, 2006 |
| First posted | Oct 26, 2005 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: